Classification, grading, staging and reporting of GU tumors continue to evolve with the discovery of pathogenic mechanisms and the advent of novel diagnostic tools and therapies. It is imperative for practicing pathologists to keep pace with the important changes in GU tumor pathology in order to produce pathology diagnoses and reports that meet contemporary patient management needs. Examples requiring educational focus are the significant error rate and inter-observer variability in the diagnosis of cribriform carcinoma and intraductal carcinoma of prostate; under-recognition and under-reporting of bladder cancer variants; misclassification of testicular germ cell tumors correlated with drastic revision of WHO 2016 classification; modifications in prostate grading correlative with newly described morphologic changes, new outcome data and adjustment to the modified Gleason grading system; changes in GU tumor staging following publication of the 8th edition of the AJCC Staging guidelines; requisite refinements in cancer reporting to eliminate significant variation, error, and missing relevant elements. This course is a pragmatic exercise in mentoring for advanced learning taught by international experts who reflect USCAP’s gold standard.
Target Audience
Practicing academic and community pathologists, and pathologists-in-training
Learning Objectives
Upon completion of this educational activity, learners will be able to:
Recognize, correctly diagnose and classify new GU tumor types
Correctly apply new and modified grading criteria for GU cancers
Correctly apply new and modified staging criteria for GU cancers
Learn new concepts and reporting requirements for GU tumors
Topics/Speakers:
Items Included in the Purchase of this Course
Update on Classification, Grading and Staging of Prostate Tumors Cristina Magi-Galluzzi, MD
Update on Classification, Grading and Staging of Kidney Tumors Ming Zhou, MD, PhD
Update on Classification, Grading and Staging of Bladder Tumors Elizabeth M. Genega, MD
Update on Classification, Grading and Staging of Testicular Tumors Sean R. Williamson, MD
